CYTK - Cytokinetics falls amid no sale announcement
2024-01-08 12:10:53 ET
More on Cytokinetics
- Cytokinetics: Clear Win For Aficamten In SEQUOIA-HCM Phase 3 Trial (Upgrade)
- Cytokinetics: Buyout Rumors Ahead Of The Key Phase 3 Readout Of Aficamten
- Cytokinetics, Incorporated (CYTK) Q3 2023 Earnings Call Transcript
- Morgan Stanley cuts Cytokinetics to equal weight but raises price target
- Needham says Cytokinetics' appeal as M&A target enhanced by HCM data
For further details see:
Cytokinetics falls amid no sale announcement